<DOC>
	<DOC>NCT00235014</DOC>
	<brief_summary>The BENEDICT study is conducted to examine the effects of an ACE inhibitor, calcium channel blockade, a combination of these, and placebo, in the prevention of micro- and macro-albuminuria in Type 2 diabetic patients.</brief_summary>
	<brief_title>A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<mesh_term>Trandolapril</mesh_term>
	<criteria>Type 2 Diabetes Hypertension Albuminuria (Phase A) Nondiabetic renal disease Subject has a hypersensitivity to ACE inhibitor, CCB</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>hypertension</keyword>
	<keyword>diabetes</keyword>
	<keyword>trandolapril</keyword>
	<keyword>verapamil</keyword>
	<keyword>albuminuria</keyword>
</DOC>